#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver abscess Myeloproliferative neoplasm Osteopetrosis Alexander disease Epilepsy Polycythaemia vera Neuroendocrine carcinoma ROHHAD syndrome Amyloidosis Lymphangioma Central nervous system lymphoma Haemophilia A with anti factor VIII Endometrial cancer recurrent Sickle cell anaemia Fibrodysplasia ossificans progressiva More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Life with Disease Netherton’s syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Myxofibrosarcoma – Trials in Disease Leiomyosarcoma – Diagnostics Shprintzen-Goldberg syndrome – Diagnostics Primary mediastinal large B-cell lymphoma – Treatment Langerhans’ cell histiocytosis Biotinidase deficiency – Diagnostics Activated PI3 kinase delta syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Caspofungin Acetate Urapidil Axicabtagene Ciloleucel Efinopegdutide Levofloxacin Deferoxamine Treprostinil Sodium Clic-1901 Cart Sodium S-Lactate Solution Gt005 SEPOFARSEN Oxogluric Acid Glucose Efzofitimod ALG-000184 Magnesium Stearate ANTIMETABOLITES ZINC CHLORIDE Zenocutuzumab Inebilizumab More therapies…

    Learn about Your Condition

    Adenomatous polyposis coli End stage renal disease EGFR gene mutation Transferrin decreased Spinal pain Cutaneous sarcoidosis Ulcerative keratitis Vascular graft thrombosis Renal transplant Asthma Arteriovenous graft thrombosis Cystic fibrosis Mucopolysaccharidosis III Wheezing Pouchitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cholangitis sclerosing

  • Study on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Elafibranor
    Germany Italy Portugal Spain

  • Study on Bezafibrate for Patients with Primary Sclerosing Cholangitis and Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bezafibrate
    France

  • Study on Pyridoxine for Patients with Primary Sclerosing Cholangitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Pyridoxine Hydrochloride
    Norway

  • Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • A3907
    France Italy Poland Spain

  • Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Volixibat
    Belgium France Germany Italy The Netherlands Spain

  • Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Norucholic Acid
    Austria Denmark Finland France Germany Hungary +3
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!